chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It has been 57 days since a patient has received 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been 57 days since a patient has received 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been 57 days since a patient has received 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been 57 days since a patient has received 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.   Reporter did not allow further contact
Site: Pain at Injection Site-Mild, Additional Details: arm still hurts after flu shot
patient received a dose of improperly stored ROTATEQ; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 02-MAR-2020, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # 1660112 exp date 18-OCT-2020), orally. There was a data logger issue involved. There were multiple temperature excursions below 2°C (1.28 °C) for a time frame of 2 hours and 30 minutes. There was no previous temperature excursion.
my daughter was perfectly healthly before she received the HPV vaccine - now she has severe migraine headaches, Reflex Sympathetic Dystrophy Syndrome, bladder and kidney infections, etc. records received 11/17/08-clinic notes for 6/17/08 C/O constant right sided temporal pain radiating throughout scalp abrupt onset 9/7/07 with Bell's palsy-at time of HPV4 vaccine and second dose of progesterone for irregular menses. Impression probably history of autoimmune induced peripheral facial weakness as well as new onset of neuralgic pain. clinic notes for DOS 9/8/08-right sided posterior occipital and temporal pain since an episode of idiopathic Bell's palsy. Pain now less. Increased neck pain now.
Fatigue,, brain fog, malaise, aching joints starting on day 14 after injection (Wed May 26), lasting four days and diminishig on Sunday May 30. Symptoms cleared until acute onset on June 1, 4 pm beginning with sharp pain thoracic spine.  Awoke at 3 am June 2 with increased persistant pain in back (4 out of 10 intensity) and unable to sleep until taking 400 mg ibuprofen.  Developed shingles rash just before noon, right side from pain origin on spine around right side across lower ribs to mid line.  Painful, itching, deep aching.
Had immunization on 4/20/11. Swelling, redness and warmth began 4/22/11. Watch/monitor for any other signs or symptoms.
Information has been received from a medical assistant concerning a 74 year old female consumer with sulfonamide, tramadol HCl (ULTRAM), ezetimibe (MSD), and omega-3 acid ethyl esters (LOVAZA) allergies, a pacemaker, depression, recurrent bronchitis, and a history of cardiac ablation, hysterectomy, knee replacement and left breast cancer who on 04-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck). Concomitant therapy included calcium (unspecified), antimicrobial (unspecified), clonidine HCl (CATAPRES), celecoxib (CELEBREX), and prednisone. Subsequently, on 04-APR-2008 the patient developed erythema, pain and swelling at the injection site after the administration of the vaccine. Medical attention was sought in the office. There were no lab studies performed. It was noted that the patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested. The patient also had an adverse experience after being placed in therapy with ezetimibe (MSD) (WAES # 0805USA03589).
Received DTaP right deltoid 7/7/03. Onset of diffuse, mildly pruritic rash right deltoid area morning of 7/9/03. Afebrile, non-tender. Treated with cold compresses and Motrin. Area of rash approx 15 cm x 10 cm.
3/22/23 My neck started getting sore, I had a little bit of a cough and temperature. I did not feel good and was very tired. I slept most of the day. My temperature continued to get higher, and I could not move my neck either way. I let this go for two days. I called my doctor on 3/24/23. He told me to go to the Emergency Room. I went to the Emergency Room. My temperature was 100.I was coughing. I did not feel good and was very tired. I had bloodwork done and an x ray of my chest which was normal.  My bloodwork showed I had a virus, but not COVID.  I was given a muscle relaxer, Amoxicillin and Probiotic Formula. I was discharged from the hospital  I am still stiff in my neck when I go to the left.
15 mins post vaccination 2nd dose, c/o chest pressure/pain 2/10 scale,  assessed by EMS,  vital signs stable BP 168/70; O2 sats 99%, heart rate 102; EKG normal. Declined transfer to hospital, signed medical release. Driven to home by fiance, pt stable.
Information has been received from a health care worker concerning a 54 year old female who on 9/28/04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (647359/0740N). Concomitant therapy included influenza virus vaccine, it was unknown when the flu shot was given. On 9/30/04, the patient developed lymph node swelling and fever. The patient was seen in the emergency room. It was also noted that the patient was hospitalized. At the time of the report, the patient had not recovered. The reporter expressed concern with lot 0740N. The reporter also mentioned 4 other female patients who were also vaccinated with a dose of pneumococcal 23v polysaccharide vaccine and developed similar reactions. No product quality complaint was involved. Lymph node swelling and fever were considered to be immediately life-threatening and disabling. Additional information has been requested. Follow up 03/03/05: Patient has not recovered from the adverse event(s).
Within 30 minutes my left arm had shooting pain down to my pinky and ring finger (which went numb for several hours) and though my left shoulder. I still have a large lump and alot of pain in my shoulder and upper arm.
This spontaneous report as received from a nurse refers to a 12 month old patient of unknown gender. On an unknown date the patient was vaccinated with a dose of PROQUAD (dose, route and lot # unknown) and VARIVAX (Merck) (dose, route and lot # unknown) on the same day. No adverse effect reported. Additional information has been requested.
On evening of receiving flu immunization developed temporary blindness in right eye. Symptoms resolved after starting medrol pack. No symptoms by evening of 10/16/02. Developed temporary blindness in right eye after vaccine 10/01 with symptoms lasting until 6/02. Connection not linked to vaccine until pt received vaccine this year and developed blindness.
4 DAYS LATER (ON AUG 20) THE INJECTION SITE IS TILL RED AND WARM BUT, ACCORDING TO  PATIENT IT IS NOT PAINFUL UNLESS IT IS BEING TOUCHED. SO I ADVISED PATIENT TO TAKE OVER THE COUNTER NSAID AND BENADRYL. AND ALTERNATING WARM AND COLD COMPRESS EVERY 30 MINUTES. YESTERDAY, I CALLED HER AND ASK HOW WAS IT. SHE SAID IT IS NOT AS SWOLLEN AS BEFORE AND IT IS BEING IMPROVED.
the patient was administered a dose of MMR II on 06-MAR-2015 and that titers drawn on an unspecified date read as negative; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs, drug reactions and allergies was not provided.  On 06-MAR-2015, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength, dose, route, anatomical location, lot # and expiration date were not provided) for prophylaxis. On an unspecified date, "titers drawn read as negative" (antibody test negative). Subsequently, on 12-FEB-2019, the patient was administered a second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength, dose, route, anatomical location, lot # and expiration date were not provided) for prophylaxis.     The outcome of antibody test negative, as well as, the causality between the event and therapy with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) were unknown.
within 20 minutes of injection of MMR, DTAP, IPV child was with fever, rash/hives.  No shortness of breath, no tracheal edema, no lung wheezes.  was treated with benadryl, oral prednisone and oral tylenol.  we observed the child for 2 hours and there were no further problems.  he was discharged with his father and was given instructions to continue the medication for 48 hours and to go to the ER if ANY problems persist, SOB or if the rash/hives return.  THis incident also reported through our pharmacy adverse reaction to be documented in the patient chart
suspected vaccination failure; shingles; rash; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure, shingles and rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient received shingles vaccine and experienced the shingles earlier this year. The patient was so glad that he/she had gotten the vaccine. The patient did not experience pain, just had a rash. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Became severely delusional, psychotic, incoherent, and combative for approximately 36 hours and went to Hospital and received sedatives, blood tests, CT scan, EEG,  MRI, chest x-ray and numerous other tests.
Pain at the injection site for about 2 days after the shot. No treatment was administered.  The pain went away on its own after 2 days.   Almost immediately after noticing that the pain from the infection site was gone, I began to notice a soreness/ache/stiffness in the area of my right elbow. This ache, which is very similar to the initial pain at the injection site, has continued since the first injection. I just received my second injection yesterday morning.   I've been hoping that the soreness will go away eventually. No treatment has been given at this time. I am planning to give it some more time to go away. If the ache continues to linger much longer,  I will see my primary care physician.
This spontaneous report was received from a pharmacist referring to a 66 or 67 year old female patient who was also a Nurse. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications were not reported. In 2016 (reported as "in July or August of this year), the patient was vaccinated with ZOSTAVAX (anatomical route of vaccination, lot number and expiration date were not provided) for prophylaxis. Approximately in 2016, the patient experienced a hard lump (injection site induration), which was painful (injection site pain) and itchy (injection site pruritus) at the insertion site. At the time of the report, the outcome of injection site induration, injection site pain and injection site pruritus was unknown. Additionally, the reporter did not provide for a causality between the adverse events and vaccination with ZOSTAVAX. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA014627:
No adverse event; Child who was given second dose of primary of 6 months to 5 years vaccine that was missed when it should have been pulled February 11, 2023, when it expired. It was given this morning by accident; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Child who was given second dose of primary of 6 months to 5 years vaccine that was missed when it should have been pulled February 11, 2023, when it expired. It was given this morning by accident) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Mar-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Child who was given second dose of primary of 6 months to 5 years vaccine that was missed when it should have been pulled February 11, 2023, when it expired. It was given this morning by accident). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Child who was given second dose of primary of 6 months to 5 years vaccine that was missed when it should have been pulled February 11, 2023, when it expired. It was given this morning by accident) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Child who was given second dose of primary of 6 months to 5 years vaccine that was missed when it should have been pulled February 11, 2023, when it expired. It was given this morning by accident).    No concomitant information was reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Mar-2023: Live follow up information received reporter details updated.
Within 60 seconds, my heart stated racing, my throat swelled and my tongue grew in size and became like sandpaper. I had a cold drink with me that I guzzled quickly and forced fluids, taking benadryl. I spiked a temperature to 99.5F within the hour. After that resolved I had 48 hours (still going) of flu like symptoms with temps up to 101.
short of breath; Sweating; get a temperature of 102 degrees/fever of 102; Vomited; Headache; tired; felt she was run over by a truck; very weak; chills; shaking; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE, Solution for injection; lot number: EN6203 and expiration date: not reported), via an unspecified route of administration,  in Left Arm, on 24Feb2021 at 08:00 (at the age of 81-year-old) as DOSE 1, SINGLE for covid-19 immunization.  Medical history included a tumor in stomach and treated with it, at the time, about 10 years ago, heparin and Experienced the same chills and things. There were no concomitant medications. on 27Feb2021, the patient experienced chills two time, vomited, headache, Tiredness, and felt she was run over by a truck, and very weak. On an unspecified date short of breath and shaking, on 08Mar2021 get a temperature of 102 degrees/fever of 102 and sweating.  The outcome of the events chills, pyrexia, vomited, Headache, Tiredness, Sweating and Weakness was not recovered, while that of the events short of breath and Feeling abnormal was unknown, and Shaking was recovered at the time of report.  No follow-up attempts are possible. No further information is expected.
pt had screaming lasting more than 12 hr, arching of back & staring gaze;t103-105;given APAP w/o relief;saw MD & given rx for advil-temp & fussiness cont x 2-3 days
pain; This case was reported by a other health professional via sales rep and described the occurrence of pain in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The Medical assistant reported a couple of patients didn't want to return for second dose due to the pain with the 1st dose.
Tested COVID-19 positive, resulted in hospital admission and ICU admission, intubation, and abnormal chest x-ray. Symptoms included shortness of breath.
Patient had RX from Dr.'s office to get the Janssen. She had an anaphylactic reaction to Pfizer. J+J consulted patient and said it was ok to still get the Janssen vaccine.  Therefore, patient got an RX from doctor. Patient tolerated the vaccine with two benadryl tablets.
Information has been received from a physician concerning a 21 year old female who on 03-OCT-2006 at 12:30 and on 18-DEC-2006 at 18:00 was vaccinated into the right and left deltoid with a first and second dose of Gardasil, respectively. On 08-FEB-2007, the patient developed genital warts. No sexual activity was reported. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. The patient was treated for the onset of a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles (onset unknown). As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Titers were drawn and patient is immune to measles and rubella and not immune to mumps; This spontaneous report was received from a registered nurse and refers to a currently 26 year old female patient. The patient's medical history, concurrent condition, concomitant medications were unknown to the reporter. On 03-SEP-1992, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, lot# and expiry date unknown) for prophylaxis. Other suspect therapies included sterile diluent (lot# and expiry date was not reported). On an unknown date, titers were drawn, and it showed that the patient was immune to measles and rubella and was not immune to mumps (mumps antibody test negative). The patient sought medical attention. No treatment was provided for the event. The outcome of the event was reported as not recovered. The causality assessment was not provided. No product quality complaint was involved.
I could not breathe/shortness of breath; I had palpitations; still have trouble going up the stairs; This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs). At the time of the report, DYSPNOEA (I could not breathe/shortness of breath), PALPITATIONS (I had palpitations) and GAIT DISTURBANCE (still have trouble going up the stairs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Blood pressure increased: high (High) high. On 13-Feb-2021, Fibrin D dimer increased (Unknown-1.6): high (High) 1.6. On an unknown date, Computerised tomogram: inconclusive (Inconclusive) inconclusive. On an unknown date, Deep vein thrombosis: inconclusive (Inconclusive) inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant history was not reported .The treatment history was not provided. the lab tests conducted are DVT, CT scan of lungs , nuclear tests with no data.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: follow up received on 23-jun-21 with non significant information
Itchy rash on my arms and my chest and things, my back and my calves in my leg; This is a spontaneous report from a contactable consumer (patient himself).   This 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EM9809), via an unknown route, on 08Feb2021 (at the age of 69-year-old male) at single dose for COVID-19 immunisation. Relevant medical history included indigestion/heart burn. Relevant concomitant medications included pantoprazole taken from an unknown date for indigestion/heart burn, and statin. About 3 to 4 days after he received the first dose he started getting an itchy rash on his arms and his chest and things, his back and his calves in his leg, and it have not gotten away and when he went to get his second dose yesterday and he told them about this symptom, they would not give him the second dose. And he is going to see a dermatologist on 15Mar2021 and he is hoping that she is going be able to tell him, if it's safe to get the second dose or what, he doesn't know where to go from here, they would not give him the dose because of the rash and he is not sure if the dermatologist is going to give him okay to get the second dose or what, he doesn't know if this is coincidence that he got the rash or what. Therapeutic measures taken as result of the events included cortisone cream. In early Feb2021, the patient had his annual physical examination including blood work-up, cholesterol, and PSA but results were not provided. The patient wish he could talk to someone that would tell him that this might be caused by the vaccine or no this is not caused by the vaccine. He realized that not seeing him in personal and stuff is difficult to make that assessment. But he just realized he is just a 'bimbo' here and he might know if he never going get the second vaccine because of the rash, so he is kind of frustrated about it. The patient had not recovered from the events.  No follow-up attempts are possible. No further information is expected.
vaccine at 4:30 pm wednesday.  next day at 10:00 am, bad headache, ached all over, overwhelming tiredness.  did not want to eat or watch tv or read.  I either slept, or lay there with my eyes open or shut.  slept all night.  next day appetite back, less tired but still so fatigued. third day all better.